Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis
Author(s)
Gopalsamuthiram, Vijayagopal; Kadam, Appasaheb L; Noble, Jeffrey K; Snead, David R; Williams, Corshai; Jamison, Timothy F; Senanayake, Chris; Yadaw, Ajay K; Roy, Sarabindu; Sirasani, Gopal; Gupton, B Frank; Burns, Justina; Cook, Daniel W; Stringham, Rodger W; Ahmad, Saeed; Krack, Rudy; ... Show more Show less
DownloadPublished version (1.021Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
A scalable four-step synthesis of molnupiravir from cytidine is described herein. The attractiveness of this approach is its fully chemical nature involving inexpensive reagents and more environmentally friendly solvents such as water, isopropanol, acetonitrile, and acetone. Isolation and purification procedures are improved in comparison to our earlier study as all intermediates can be isolated via recrystallization. The key steps in the synthesis, namely, ester formation, hydroxyamination, and deprotection were carried out on a multigram scale to afford molnupiravir in 36-41% yield with an average purity of 98 wt % by qNMR and 99 area% by HPLC.
Date issued
2021-12-17Department
Massachusetts Institute of Technology. Department of ChemistryJournal
Organic Process Research & Development
Publisher
American Chemical Society (ACS)
Citation
Gopalsamuthiram, Vijayagopal, Kadam, Appasaheb L, Noble, Jeffrey K, Snead, David R, Williams, Corshai et al. 2021. "Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis." Organic Process Research & Development, 25 (12).
Version: Final published version